ha14-1 and pd 184352
ha14-1 has been researched along with pd 184352 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Andreeff, M; Carter, BZ; Estrov, Z; Harris, D; Huang, Z; Konopleva, M; Kornblau, SM; Leysath, CE; Lopez-Berestein, G; Milella, M; Schober, WD; Tari, A | 1 |
Other Studies
1 other study(ies) available for ha14-1 and pd 184352
| Article | Year |
|---|---|
Synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute myelogenous leukemia.
Topics: Antineoplastic Agents; Apoptosis; Benzamides; Benzopyrans; Drug Synergism; Enzyme Inhibitors; Humans; Leukemia, Myeloid, Acute; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Nitriles; Oligonucleotides, Antisense; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured | 2002 |